Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

CALC Episode 1: From Molecule to Patient: The Statistician’s Role in Developing New Medicines

CALC Episode 1: From Molecule to Patient: The Statistician’s Role in Developing New Medicines

FromThe Effective Statistician - in association with PSI


CALC Episode 1: From Molecule to Patient: The Statistician’s Role in Developing New Medicines

FromThe Effective Statistician - in association with PSI

ratings:
Length:
37 minutes
Released:
Oct 23, 2019
Format:
Podcast episode

Description

How do we develop new medicines to treat nasty diseases? It all starts by discovering a novel target molecule in the lab. Fast forward 12 years and an average expenditure of 1.5 billion dollars we hopefully get the thumbs up from health authority bodies to license the medicine for public use.
So we skipped a lot of important steps there. The journey for developing new medicines is extremely lengthy and complicated. Fortunately, you can listen to this podcast and know all the important stuff in 20 minutes!
Statisticians are involved in all aspects of drug development. Having knowledge of the process from start to finish is important, as it will help you understand why statistics is an essential and relied upon toolkit in this industry.
- Quick overview of the drug development process
- Where and why statisticians add value in the process
- Key stakeholder interactions - who do statisticians collaborate with?
Released:
Oct 23, 2019
Format:
Podcast episode

Titles in the series (100)

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.